Ignite Creation Date:
2024-05-06 @ 2:51 PM
Last Modification Date:
2024-10-26 @ 1:38 PM
Study NCT ID:
NCT04443309
Status:
RECRUITING
Last Update Posted:
2023-03-29
First Post:
2020-06-21
Brief Title:
Lenvatinib in Combination With Camrelizumab as First-Line Therapy in Patients With Advanced HCC
Sponsor:
Peking Union Medical College Hospital
Organization:
Peking Union Medical College Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hepatocellular Carcinoma |
Keywords: